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apoptosisCalcium handling by mitochondria is a key feature in cell life. It is involved in energy production for cell
activity, in buffering and shaping cytosolic calcium rises and also in determining cell fate by triggering or
preventing apoptosis. Both mitochondria and the mechanisms involved in the control of calcium
homeostasis have been extensively studied, but they still provide researchers with long-standing or even
new challenges. Technical improvements in the tools employed for the investigation of calcium dynamics
have been–and are still–opening new perspectives in this ﬁeld, and more prominently for mitochondria. In
this review we present a state-of-the-art toolkit for calcium measurements, with major emphasis on the
advantages of genetically encoded indicators. These indicators can be efﬁciently and selectively targeted to
speciﬁc cellular sub-compartments, allowing previously unavailable high-deﬁnition calcium dynamic
studies. We also summarize the main features of cellular and, in more detail, mitochondrial calcium
handling, especially focusing on the latest breakthroughs in the ﬁeld, such as the recent direct
characterization of the calcium microdomains that occur on the mitochondrial surface upon cellular
stimulation. Additionally, we provide a major example of the key role played by calcium in patho-physiology
by brieﬂy describing the extensively reported–albeit highly controversial–alterations of calcium homeostasis
in Alzheimer's disease, casting lights on the possible alterations in mitochondrial calcium handling in this
pathology.hondrial membrane potential;
e resonance energy transfer;
asmic reticulum Ca2+ concen-
M, calmodulin; CCE, capacita-
Cyp D, cyclophilin D; mCU,
ulum; FAD, familiar Alzheimer
ECI, genetically encoded Ca2+
itochondrial membrane; IMS,
1,4,5-trisphosphate; IP3R, IP3
, plasma membrane; PMCA,
resenilin-2; PTP, permeability
henium Red; SERCA, sarco/
pathway Ca2+ ATPase; SR,
annel; YFP, yellow ﬂuorescent
, Dept of Biomedical Sciences,
Italy. Tel.: +39 049 827 6067;
as), ilaria.drago@unipd.it
.pozzan@unipd.it (T. Pozzan).
ll rights reserved.© 2010 Elsevier B.V. All rights reserved.1. Introduction
Calcium-based signalling is a universal mechanism through which
extracellular messengers modify the activity of target cells. Cells can
decode Ca2+ signals based on the characteristics of the intracellular
changes in Ca2+ concentration (amplitude, duration, frequency and
localization) and generate outputs as diverse as proliferation or death.To this end, eukaryotic cells have evolved a complex Ca2+ toolkit that
encompasses proteins capable of detecting changes in Ca2+ levels
(and thus trigger a signalling cascade through effectors), as well as
complex homeostatic mechanisms that include Ca2+ channels on the
plasma membrane and organelles, Ca2+-buffering proteins, and
systems for Ca2+ extrusion and sequestration [1–5].
Cytosolic Ca2+ concentration ([Ca2+]c) in basal, resting conditions is
a steady state that depends exclusively on the equilibrium between the
inﬂux and efﬂux rates at the plasmamembrane (PM) level. Any change
in the activity or concentration of other members of the Ca2+ toolkit
(e.g., buffers, organelle pumps, etc.) affect cytosolic Ca2+ levels only
transiently andhavenoeffect on the long-termconcentrationof this ion.
Surprisingly, this basic and essential concept is not obvious to all
investigators in the ﬁeld (see the recent contribution by Rios where
these concepts are described in an elegant, accurate and formally
impeccableway [6]). Cytoplasmic Ca2+signals (i.e., increases in [Ca2+]c)
may be due to (i) Ca2+ entry from the extracellularmatrix (through the
PM), or (ii) Ca2+ release from intracellular stores, or a combination of
both. At the end of the signal, basal [Ca2+]c levels are regained through
the action of pumps or antiporters at the expense of energy
consumption. Organelles must be reﬁlled as well through their speciﬁc
Ca2+ uptake systems that take advantage of selective pumps (SERCA,
SPCAs) or exchangers.
Although the endoplasmic reticulum(ER) and its specialized form in
muscle (the sarcoplasmic reticulum, SR) is generally considered the
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Ca2+ signalling [3,5]:mitochondria (see below), theGolgi apparatus [7],
secretory vesicles [8], lysosomes [9], endosomes [10] and peroxisomes
[11,12].
Much attention has been dedicated over the last decades to the
involvement of mitochondria in Ca2+ homeostasis: mitochondria are
known since the late 1960s to be endowed with the capacity of
accumulating Ca2+ in an energy-dependentway (through the so-called
Ca2+ uniporter, mCU) and in the 1970s the existence of antiporters
capable of releasing Ca2+ from these organelles was ﬁrmly established
(Na+ dependent and independent Ca2+ exchangers). The kinetic
characteristics of mitochondrial Ca2+ transport are well known, but
the proteins involved have yet to be identiﬁed at the molecular level
[13–15], although somecandidates havebeenpresented recently for the
mCU [16,17] and the Na+/Ca2+ antiporter [18].
For a long time, however, due to the lowafﬁnity of themitochondrial
Ca2+ uptake system under physiological conditions (Kd around
10–20 µM) this process was considered to take place only at
pathophysiological [Ca2+], i.e., in conditions of cellular Ca2+ overload
[3,19–21]. A number of observations, in contrast with this over-
simpliﬁed view, were largely overlooked by the scientiﬁc community
for quite some time. In particular, it was known that mitochondrial key
functions (matrix dehydrogenases inparticular) are strongly affected by
[Ca2+] within the matrix [22]. In addition, it was well known that
cytosolic Ca2+ can inﬂuence the activity of mitochondrial enzymes
located on the outer surface of the inner mitochondrial membrane
(IMM), such as glycerophosphate dehydrogenase, or the malate-
aspartate shuttle and glutamate/malate dependent respiration through
activation of the aspartate-glutamate carriers [23,24]. It was, however,
the demonstration that physiological cytosolic Ca2+ increases are
accompanied by similar and larger mitochondrial ones that made the
process of mitochondrial Ca2+ regulation one of wide interest. Finally,
the discovery that excess Ca2+ uptake by mitochondria triggers a
bioenergetic failure of the organelle through the opening of the
permeability transition pore (PTP, [25]), release of cytochrome c and
of other proapototic factors and cellular death by apoptosis or necrosis,
has deﬁnitively put the study of mitochondrial Ca2+ homeostasis at the
centre of interest of a vast group of scientists [26].
Pivotal in this renewed interest in mitochondrial Ca2+ homeostasis
was the development of Ca2+ indicators that enable the accurate
quantiﬁcation of the concentration of this cation in the matrix of
organelles in living cells. Such probes, either synthetic or natural, exhibit
quantiﬁable changes in some physicochemical property, most com-
monly an alteration in the spectrophysical properties (ﬂuorescence
intensity and/or wavelength shift), that are proportional to [Ca2+].
Numerous probes are currently in use,with each possessing advantages
and disadvantages. At present, the wide choice of such Ca2+ indicators
offers a solution for almost any biological problem. The genetically
encoded Ca2+ indicators (GECIs) are, in our opinion, the best choice
because of their highly selective targeting to subcellular compartments,
long-term expression when integrated into the genome, and marginal
or no toxicity.
In this contribution, we will ﬁrst brieﬂy review the state-of-the-art
concerning the different types of Ca2+ probes and their use in living
cells, with emphasis on the newly generated GECIs and their use in the
determination of Ca2+ handling by organelles. We will then address
mitochondrial Ca2+ handling and its relevance in physiology and
pathology, also focusing on recent ﬁndings by our group in cell models
of Alzheimer disease.
2. Ca2+ measurements in living cells
The 1960s and 1970s saw the identiﬁcation of some organic
compounds (murexides and azo dyes in particular) that were able to
change spectral properties upon Ca2+ binding. However, these probes
had no ﬁxed stoichiomestry, exhibited low signal-to-noise ratio, andhad to be laboriously delivered into cells by microinjection [27]. Given
that these dyes could, in the best case, be trapped only within the
cytosol, they could only provide indirect information of organelle Ca2+
handling. The invention in the early 1980s by Tsien and coworkers of a
new family of synthetic ﬂuorescent Ca2+ indicators that could be easily
delivered to cells by incubation with their acetoxymethyl ester
derivatives represented a breakthrough in the ﬁeld of Ca2+ imaging
([28–30], Table 1). Tens of Ca2+ indicators have been generated based
on the sameprinciples (most of thembyTsien's group) and the available
probes presently cover a wide range of Ca2+ afﬁnities and spectral
properties. For example, some indicators only increase the emitted
ﬂuorescence upon Ca2+ binding (e.g., Calcium-Green, Fluo-3), whereas
in other cases Ca2+causes a shift in either theexcitation (Fura-2) and/or
emission spectra (Indo-1) [27]. Since the esterases that hydrolyze the
AM forms are primarily (though not only) located in the cytoplasm,
these indicators cannot be speciﬁcally targeted to organelles or
subcellular compartments, with Rhod-2 being the only possible
exception. Trapping of the ﬂuorescent dyes in organelles does occur
under some conditions, but this is never selective (again with the
exceptionofRhod-2). Recently it has been shown that selective labelling
of organelles with these dyes can be obtained by over-expressing
esterases in speciﬁc locations within the cell [31]. This interesting
approach, however, has not gained much popularity yet. The only Ca2+
probe of this family that shows some speciﬁcity in subcellular trapping
(to the mitochondrial matrix) is Rhod-2. Rhod-2 in fact possesses, in
both the AM and hydrolyzed form, a delocalized positive charge that
favours its accumulation inside the mitochondrial matrix due to the
negative membrane potential across the inner membrane of this
organelle. In most cases, however, partial mislocalization of Rhod-2 in
the cytoplasm and other compartments is observed and speciﬁc
protocols had to be devised to take this problem into account. Also,
given that Rhod-2 responds to Ca2+ rises with an increase in
ﬂuorescence intensity, ratiometric imaging is not feasible and artefacts
due to different dye loading or organelle movements cannot be easily
compensated for [32]. Other concerns raised by these indicators are the
toxicity of the de-esteriﬁcation reaction products (acetate and formal-
dehyde) and, in some cases (e.g., fura-2 and indo-1), the photodamage
that can result upon prolonged excitation with high energy photons
[27,33,34].
The targeting problem was elegantly solved with GECIs, because
the transfected proteins can be selectively targeted to the subcellular
compartment of interest by including in their sequence speciﬁc signal
peptides [35–39]. GECIs can be expressed under the control of
inducible or tissue speciﬁc promoters, and therefore the amount of
indicator and type of cell can be modiﬁed or selected. All available
GECIs are based on two proteins present in the jellyﬁsh Aequorea
victoria: aequorin and green ﬂuorescent protein (GFP). GECIs can be
subdivided in bioluminescent (based on aequorin) and ﬂuorescent
probes (based on GFP and its mutants).
Bioluminescent GECIs take advantage of the emission of a photon in
the reaction of peroxidation of the cofactor coelenterazine, which is
catalyzed by aequorin in the presence of Ca2+. The rate of photon
emission is proportional to the [Ca2+], thus enabling thedetermination at
any instant of the local [Ca2+] in the environment where the protein is
localized. Furthermore, asnoexcitation isneeded (photonemission is the
result of a chemical reaction), in experiments employing aequorin the
background noise is essentially due to instrumental noise and thus very
low. Initially, aequorin had to be laboriously extracted from jellyﬁsh [40],
but cloning of its cDNA not only permitted heterologous cell expression,
but also allowed genetic engineering of the protein to modify the Ca2+
afﬁnity and to deliver it to speciﬁc organelles [27,35,36,41,42]. For
example, targeting of aequorin to subcellular compartments allowed to
demonstrate that mitochondria in living cells respond to physiological
changes of [Ca2+] in the cytoplasm [43], to unravel the ER–mitochondria
relationship [44,45] and to prove that the Golgi apparatus acts as a
releasable Ca2+ reservoir [7]. Themain disadvantages of aequorin-based
Table 1
Commonly used Ca2+ indicators (chemically synthesized) and GECIs.
Response to [Ca2+ ] λ excitationa
(nm)
λ emissionb
(nm)
Kd for Ca2+ μM
(in situ)c
Observations REF
Quin-2 Fluorescence intensity 340 495 0.115 NSTd [30]
Indo-1 Ratiometric 345 400 / 480 0.25 NSTd Ratiometric emission
400(Ca2+ bound)/480 (Ca2+ free)
[180]
Fura2 Ratiometric 340 /380 510 0.224 NSTd Ratiometric excitation
340 (Ca2+ bound)/380 (Ca2+ free)
[180]
CalciumGreen-1 Fluorescence intensity 504 532 0.19 (0.93) NSTd [34]
Oregon Green
488 BAPTA-1
Fluorescence intensity 488 520 0.17 (0.43) NSTd [34]
Fluo-3 Fluorescence intensity 488 520 0.39 (0.81) NSTd [32,34]
Fluo-4 Fluorescence intensity 488 520 0.345 (1) NSTd [32,34]
Rhod-2 Fluorescence intensity 540 580 1–0.570 Tends to accumulate in the mitochondrial
matrix
[32,181]
Aequorins Increase rate of photon emission
(luminescence)
∼470 7 Aequorins with different afﬁnities for
Ca2+ are available
[41,182]
GFP-Aequorin Increased BRET 510 Similar to Aeq [47,50]
Camgaroo-1 Fluorescence intensity 490 514 7 [52]
Camgaroo-2 Fluorescence intensity 490 514 5.8 (8) [57,183]
R-Pericam 1.7 [51]
R-Pericam mt Ratiometric 400 (Ca2+ free) 514 (11) Targeted to the mitochondrial matrix [38,45]
2mt8RP 490 (Ca2+ bound) (2) Targeted to the mitochondrial matrix [38]
R-Pericam nu (2.5) Targeted to nucleus [45]
Inverse pericam Fluorescence intensitiy 490 514 0.2 (0.9) [51,183]
GCaMP1.6 Fluorescence intensity 490 514 1.23 (0.64) [184,185]
GCaMP2 Fluorescence intensity 490 514 n.d. (0.75) [185]
Cameleons Ratiometric (FRET changes) 430 460–500 Citrine / cpve [60,185]
(CFP) D1: 0.8, 60 / –
525–580 D2: 0.8; 26/ 0.03, 3
(YFP) D3: 1.2 / 0.6 (0.49)
D4: 195/ 64
Tn-L15 Ratiometric (FRET changes) 430 460–500 0.72(0.36) M [61,185]
(CFP)
525–2580
(YFP)
Tn-XL Ratiometric (FRET changes) 430 460–500 2.5 (0,77) M [62,185]
(CFP)
525–2580
(YFP)
Tn-XXL Ratiometric (FRET changes) 430 460–500 0.8 (reduced in
situ)
[61–63]
(CFP)
525–580
(YFP)
a The wavelength most often employed for excitation.
b The wavelength most often employed for emission.
c Reported in vitro afﬁnity for Ca2+ and, when available, the corresponding apparent Kd determined in situ are given between brackets. Please note that the Kd may change from in
vitro to in situ conditions and also between different compartments.
d NST: not selectively targetable. Targeting of esterases has been recently proposed to obtain selective accumulation of these dyes into speciﬁc organelles.
e For these probes, the different in vitro afﬁnities of the variants with citrine or circular permuted venus (cpv) are given for the 4 cytosolic designs.
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“consumed” and accordingly the amount of responsive probe decreases
with time, the faster the higher the [Ca2+] [37,46]; (ii) the low amount of
photons emitted (less than1photon/molecule); and (iii) thenecessity of
a cofactor, coelenterazine, to reconstitute the active Ca2+ indicator.
In the jellyﬁsh, GFP emits ﬂuorescence after energy transfer from
Ca2+ bound aequorin, in a process known as bioluminescence
resonance energy transfer (BRET). BRET probes can be generated by
fusing GFP and aequorin, and changes in [Ca2+] result in modiﬁcations
of GFP ﬂuorescence intensity [47]. An advantage of this GECI over
aequorin is that becauseGFPﬂuorescence is red shifted compared to the
photons emitted by aequorin, absorption of light from tissues is less
important and the quantum efﬁciency is slightly higher [48]. Indeed,
GFP-aequorin has been used not only in cell cultures, but also in vivo,
both in Drosophila melanogaster [49], and in mammals, where it has
been successfully employed to monitor [Ca2+] changes within cyto-
plasm and mitochondria in the free moving mice [50].
TheGECIs basedonGFPcanbedistinguished inprobes containingone
or two GFP variants fused to a Ca2+ sensor, usually calmodulin (CaM). A
ﬁrst group of such probes containing one GFP molecule (the prototypebeing “camgaroos”) exhibits only a change inﬂuorescence intensityupon
Ca2+ binding to the sensor. Another group, the prototype being
“ratiometric pericams,” consists of a circularly permutedYFP sandwiched
between CaM and its interacting peptide frommyosin light chain kinase,
M13. Ca2+ binding to CaM results in change in the excitation spectrumof
circularly permuted YFP and accordingly the [Ca2+] can be directly
obtained from the ratio between two excitation wavelengths [51]. In all
these probes, GFP ﬂuorescence is quite sensitive to pH changes [52,53]. A
major problem in all the above-mentioned probes is that the Ca2+
sensors is represented by CaM, which is widely expressed in all cells and
participates in a variety of signalling events. Therefore, concerns were
raised on the possible interference of the probewith endogenous targets.
Recently Zou and co-workers [54] generated a GECI similar to pericam in
which only the CaM loop III and its ﬂanking helices were inserted in the
EGFP sequence, in the attempt to override the potential problem of
interferencewithendogenousCaM-dependent reactions.Other solutions
to this problem have been found, see below.
A third group of GFP-based GECIs exhibits a change in ﬂuorescence
resonance energy transfer (FRET) between two mutants of GFP upon
Ca2+ binding to the sensor. In 1997, two such FRET-based probeswere
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inserted the CaM interacting peptide M13 between a blue (FRET
donor) and green (FRET acceptor) variants of GFP. In this probe FRET
is maximal at low [Ca2+] and energy transfer between the two GFP
mutants is abolished when the Ca2+–CaM complex binds to the M13
and increases the distance between the donor and acceptor
molecules. The other sensor was generated in the group of Tsien
and was named “cameleon.” In this case, CaM and M13 were fused in
tandem between the blue and green GFP mutants: binding of Ca2+ to
CaM resulted in wrapping around of CaM to M13 and this led to an
increase in FRET between the two GFPs [56]. Many improvements to
the original cameleons were introduced in the following years to
enhance the dynamic range of the FRET changes and to decrease the
interference with medium composition. First, the blue and green GFP
mutants were substituted by the more suitable FRET pair cyan and
yellow ﬂuorescent proteins (CFP and YFP). Given that YFP is quite
sensible to pH, a new family of cameleons was generated in which YFP
was substituted by the mutant “citrine” that is much less pH sensitive
[57]. Finally, Miyawaki's group produced a novel YFP called Venus,
that bears mutation causing a decrease in pH and [Cl−] sensitivity and
a faster maturation of the chromophore at 37 °C [58]. The use of these
new YFPs and of their circularly permuted counterparts in cameleons
substantially improved the dynamic range of the FRET changes upon
Ca2+ binding [59]. Cameleons in which the Ca2+ binding sites of CaM
were purposely mutated were also produced, resulting in a family of
FRET based probes with vastly different Ca2+ afﬁnities.
Finally, in an elegant work by Palmer and co-workers [60],
interference from endogenous CaM was drastically decreased by
engineering both CaM and M13. In particular, by means of computa-
tional analysis of the binding interface between CaM and M13, new
peptide pairs aimed at abolishing the interaction between theM13with
endogenous CaMwere generated bymutagenesis. Probeswith different
Ca2+ afﬁnities were also generated by this approach. Thus, new
cameleons bearing both citrine (D1, D2, D3, D4) or circularly permuted
Venus (D-cpv) with sensitivities covering a 100 fold range of [Ca2+]
(Kds between 0.6 and 60 µM) were produced, all highly insensitive to
endogenous CaM. For example, D1 is suitable tomeasure [Ca2+] ranging
from 1 µM up to 300 µM, whereas D2cpv would be more indicated to
detect modest elevations above basal Ca2+ levels and D4cpv is ideal for
subcellular compartments with very high [Ca2+] [60].
A different approach to avoid interference by endogenous CaM
was also devised by Heim and co-workers, who chose as Ca2+
sensor murine troponin-C from skeletal muscle, the rationale being
that troponin-C is speciﬁcally expressed in skeletal muscle and
should not have endogenous binding proteins in other cell types.
The ﬁrst generation of these probes (Tn-L5) was later improved by
molecular rearrangement of the Ca2+ sensor portion, thus reducing
the interference of Mg2+ while maintaining a good FRET perfor-
mance with a Kd for Ca2+ of 800 nM. The improved probe, termed
Tn-XXL was successfully expressed in hippocampal organotypic
slices and also in vivo. The authors performed Tn-XXL electropora-
tion in utero or virus injection in adult animals and were able to
perform single cell measurements both in cell cultures and in vivo.
Noteworthy, the probe expressed in vivo via viral infection was
stable over time and repeated experiments could be performed
through a cranial window several weeks after the initial injection of
the viral vector [61–63].
As pointed out previously, GECIs (and therefore cameleons) can be
efﬁciently localized to subcellular compartments by fusionwith speciﬁc
targeting sequences [35,60,64]. However, as far as targeting of
cameleons to the mitochondrial matrix is concerned, the initial results
were disappointing. Introduction at theN-terminal end of cytochrome c
oxidase subunit VIII (COX-VIII) targeting sequence, that is very efﬁcient
in localizing camgaroos and pericams to the mitochondrial matrix,
resulted in very poor localization of the cameleons in themitochondria,
while the majority of the probe was mislocalized to the cytosol. Theproblem was largely overcome by inserting multiple targeting
sequences in tandem at the N-terminus of the cameleon; in cells
transfected with cameleon containing 8 repeats of COX-VIII almost no
mislocalization of the probe was observed, but at the expense of
affectingmitochondrial shape and viability; 2 and 4 repeats appear to be
the best compromise between localization and toxicity [38,60].
FRET-based sensors are ideally suited for single and multi-photon
confocal microscopy, given that most commercial apparatuses are
routinely equipped with the possibility of monitoring contemporarily
two or more emitted wavelengths while alternating two exciting laser
beams is technically and economically highly demanding [65,66].
Several strategies are available to deliver the probes to cells,
tissues, and organisms, from transfection techniques to viral
constructs. Cameleons have been efﬁciently delivered to cultured
cells and in vivo expression has been obtained by either the use of
viruses or in utero electroporation [67]. Recently, transgenic
animals with cameleon expressed under the control of a tissue/
cell speciﬁc promoter [68] or under TET control [69] have also been
generated.
3. Microdomains: the mitochondria–ER connection
The central role of mitochondria in cellular Ca2+ homeostasis is now
an established concept in cell biology. Ca2+ entry into the mitochondrial
matrix is mediated by an inwardly rectifying ion channel, the mCU [70].
Recently, it has been suggested that more than one mCU may be
expressed by mitochondria [71,72] and an alternative Ca2+ inﬂux
pathway (a Ca2+/H+ antiport) has been proposed by Jiang and
coworkers [16]. Ca2+ entry through themCU is driven by themembrane
potential (negative inside;ΔΨm) that exists across the IMM.Since [Ca2+]c
in resting condition is around 100 nM and the ΔΨm due to respiratory
chain activity is ∼ −180 mV, the prediction is that at electrochemical
equilibrium, [Ca2+]m could reach values as high as 0.1 M [73]. However,
this value is never reacheddue to the existence of efﬂuxmechanisms that
couple Ca2+ extrusion to H+ or Na+ entry down their electrochemical
gradient (see below). Thus, the steady state Ca2+ level in the
mitochondrial matrix is far from electrochemical equilibrium due to a
futile cycle of Ca2+ entry and exit across the IMM. The energy cost of this
cycle is relatively modest, since the mCU has a low Ca2+ afﬁnity
(Kd around 10–20 µM) [74] and thus the Ca2+ uptake rate, particularly
under resting conditions, is extremely slow. Based on this consideration,
it was long assumed that mitochondrial Ca2+ uptake was of little
importance in cell physiology since [Ca2+]c, even upon stimulation,
reaches values far below the [Ca2+] required for strong mCU activation.
Therefore, mitochondrial Ca2+ uptake was regarded as a safeguard
mechanism put in action when pathological elevations of Ca2+ occur.
This idea was initially challenged by the demonstration that mitochon-
drial oxidative metabolism was dependent on the matrix [Ca2+], due to
the Ca2+ dependency of three matrix dehydrogenases (for a recent
review see [22]). The breakthrough in our understanding of the
importance of mitochondrial Ca2+ uptake in physiology, however, was
the demonstration (using genetically encoded Ca2+ probes targeted to
the mitochondrial matrix) that [Ca2+]m could reach values up to tens or
hundreds micromolar upon [Ca2+]c rises of a fewmicromolar [43,75]. In
order to reconcile in vitro experiments that unambiguously proved the
low Ca2+ afﬁnity of mCU with the data obtained by measurement of
[Ca2+]m in intact cells, the so-called “microdomain hypothesis” was
proposed [43,44]. According to this hypothesis, the fast mitochondrial
Ca2+ uptake in intact cells depends on the close apposition between
mitochondria and the sites of Ca2+ release/inﬂux. In other words, the
mCU in intact living cells can locally experience a [Ca2+] that is much
higher than thatmeasured in the bulk cytosol, i.e., high enough to ensure
a strong activation of the uptake mechanism. The hypothesis was
supported by a large body of indirect evidence, though the existence and
amplitude of high Ca2+ microdomains on the surface of mitochondria
was demonstrated directly only very recently (see below Section 3.1).
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Despite intense investigations on the mCU for almost 50 years, the
molecular identity of this gated channel is still a matter of debate.
Recently, Graier and co-workers [17] proposed that uncouplingproteins
UCP2 and 3 are fundamental components of themCU. In particular, they
showed that over-expression of these proteins causes an increase,while
their silencing or mutagenesis cause a decrease, in mitochondrial Ca2+
accumulation. Moreover, mitochondria isolated from liver of UCP2−/−
mice did not show a Ruthenium Red (RR)-sensitive Ca2+ uptake.
However, mitochondria from UCP2 or 3 expressing cells of Saccharo-
myces cerevisiae failed to show a RR-sensitive Ca2+ uptake, thus
highlighting that these proteins alone cannot constitute the mCU. On
the other hand, these ﬁndings have been challenged bymeasuring Ca2+
uptake in heart and liver mitochondria [76]. This latter group showed
that, notwithstanding the higher expression of UCPs in heart, there is no
signiﬁcant difference in mitochondrial Ca2+ uptake rate between heart
and liver and, most importantly, no effect of UCPs inhibitors on Ca2+
uptake by mitochondria was observed. Moreover, in conﬂict with
Graier's group data, no Ca2+ uptake variation was measured in
mitochondria from neither UCP2−/− nor UCP3−/− mice. The effect on
mitochondrial Ca2+ entry upon UCPs silencing or over-expression in
HeLa cellswas not reproduced by several groups (see for example [16]).
Other candidates to play the role of mCU have been proposed in
the last years, in particular a mitochondrial Ryanodine receptor (RyR),
that was identiﬁed and characterized only in heart mitochondria
[77,78]. How a protein endowedwith a speciﬁc targeting sequence for
the ER/SR membrane could end up into the inner mitochondrial
membrane remains mysterious. The possibility that this RyR in the
heart mitochondrial fraction represents a contamination from the
bona ﬁde RyR of the SR has not been completely excluded.
In the last months major interest has received the report that the
IMM protein Letm1 could be a Ca2+/H+ antiporter, catalyzing the
uptake of Ca2+ into mitochondria. This protein was identiﬁed as a
possible player inmitochondrial [Ca2+] homeostasis by a genome-wide
RNAi high-throughput screening in Drosophila S2 cells stably expres-
sing themitochondrial targetedCa2+ andH+probe Pericam [16]. Letm1
was ﬁrstly characterized as a gene involved in Wolf–Hirschhorn
syndrome, a disease due to hemizygous deletion of a set of genes on
chromosome 4 [79]. In particular, lack of Letm1 is thought to be the
cause of the seizures that characterize this syndrome [80]. Up until the
report of Jiang and co-workers, Letm1 (and its yeast homolog, Mdm38)
wasbelieved to be themitochondrial H+/K+antiport. This conclusion is
supportedby anumberof strongdata inyeast,mammals andDrosophila
[81–83]. In their recent paper, Jiang and co-workers, on the contrary,
demonstrate in intact and permeabilized cells that Letm1 down-
regulation reduces mitochondrial Ca2+ increases (at low [Ca2+]) and
that its over-expression enhances the organelle Ca2+ uptake. Moreover,
they showed that partially puriﬁed Letm1 can recreate a RR- sensitive
Ca2+uptakewhen reconstituted in liposomes. Surprisingly Jiang and co-
workers concluded that Letm1 is not the mCU or one of its key
components, but rather anadditional Ca2+uptakemechanism, a 1Ca2+/
1H+ antiport. This latter conclusion is particularly surprising, given that
it has been ﬁrmly established that Ca2+ uptake into the mitochondria
results in the net transfer of 2 positive charges across the membrane.
Our biased opinion is that, as hypothesized by McQuibban and
colleagues [83], the effect on mitochondrial Ca2+ transport of Letm1
down regulation/over-expression is a secondary effect of a decreased
K+/H+ exchange activity.
Several reports have been published in the last few years
describing the modulation of mCU activity by protein kinases: PKD
[84] and PKC isoform β/δ have been reported to inhibit it, while PKC
isoform ζ activates it [85]. Studies with the p38 MAPK inhibitor
SB202190 suggested that also this kinase can inhibit mCU (but see
[86] for an alternative explanation). Additional evidence in support of
a role of p38 MAPK has been reported by the group of Spat [87]. Amajor problem in interpreting these results is that themCU is believed
to be a protein of the IMM, thus insulated from the catalytic activity of
cytosolic kinases such as p38, PKC and PKD by the protein-
impermeable outer mitochondrial membrane.
There is also some evidence that themCU can be slowlymodulated
by Ca2+ itself. For example a few minutes pre-incubation in Ca2+ of
de-energized mitochondria results in a substantial activation of Ca2+
uptake upon providing an energy source [88]. Moreau and colleagues
[89] suggested that this process of activation needs a Ca2+–CaM
intermediate, since use of CaM inhibitors impair mCU activation.
Given the well known side effects of most CaM inhibitors, this latter
conclusion must be taken with caution.
Finally a word of warning as to the use, in living cells, of RR and its
puriﬁed formRu360 as an inhibitor ofmCU. RR can bindmany proteins
with different afﬁnities (e.g., it is a good inhibitor of the RyR) and given
that these compound possesses six positive charges it should not be
easily permeable across the PM. Although several reports have been
published reporting indirect evidence suggesting that extracellularly
added RR or Ru360 can inhibit mitochondrial Ca2+ uptake of intact
cells, in our hands addition of RR or Ru360 to intact cells has never
resulted in a speciﬁc inhibition of mitochondrial Ca2+ uptake.
As to the efﬂux mechanisms, Ca2+ can be extruded from the matrix
by Na+-dependent or independent mechanisms. The Na+-dependent
mechanism exchanges 1Ca2+ with 3Na+ and thus is electrogenic,
similarly to the PM isoform [90]. This antiport is mainly found in
excitable tissues, e.g., brain and heart, and it is inhibited by CGP37157
[91]. Recently, strong evidence has been provided that the Na+/Ca2+
exchanger isoform NCLX is the long-sought protein responsible for the
mitochondrial Na+-dependent Ca2+ efﬂux [18]. The Na+-independent
mechanism couples the extrusion of 1 Ca2+ to the entry of 2(3) H+ and
it is predominant in non-excitable cells [92]. The low conductancemode
of themitochondrialmegachannel or permeability transition pore (PTP)
can be also considered as a non-saturating mechanism for Ca2+ efﬂux
from mitochondria. When open, PTP allows the passage of ions and
molecules up to 1.5 kDamolecular weight, including Ca2+. PTP opening
is causedby conditions ofmitochondrial Ca2+overload, especiallywhen
these occur in concurrence with oxidative stress, high levels of
phosphate and adenine nucleotide depletion (for a recent review see
[25,93]. Upon PTP opening and thus mitochondrial ΔΨ loss, Ca2+ can
exit also through the mCU.
As described above, the “Ca2+ microdomain” hypothesis explains
the paradox of a low Ca2+ afﬁnity mCU and a highly efﬁcient
mitochondrial Ca2+uptake underphysiological conditions, by assuming
that amitochondrial subpopulation is positioned in very closeproximity
to Ca2+ release sites from ER or Ca2+ entry sites from PMwhere [Ca2+]
can reach values higher than those in the bulk cytosol. Since the
formulation of the hypothesis, many data supporting it have been
reported. For example the existence of mitochondria–ER close apposi-
tions was demonstrated by high resolution microscopic analysis of
living cells expressing mitochondrial and ER-targeted GFP mutants;
electron microscopy analysis of quickly frozen samples has also
conﬁrmed that mitochondria are often closely apposed to either the
ER or the PM [94]; through an aequorin targeted to the intermembrane
space of mitochondria, a [Ca2+] slightly higher than the cytosolic one
was measured upon cellular stimulation [44]. Based on these and other
ﬁndings, it has been suggested that mitochondria can be divided into
two populations, one located in close contact to Ca2+ release sites and
thus rapidly accumulating Ca2+ upon cellular stimulation, one that
experiences smaller Ca2+ levels, close to that of the bulk cytosol [45],
and takes up Ca2+muchmore slowly. The proximity ofmitochondria to
Ca2+ release sites is also supported by the demonstration that a physical
linker between the two organelles exists [95] and also by the
identiﬁcation of proteins that can act as tethers, like grp75, a chaperone
linking VDAC1 and IP3R [96], and mitofusin-2, that is expressed in ER
and mitochondria surfaces and forms homodimers or heterodimers
with mitofusin-1 [97,98]. Moreover, an ER–mitochondria tethering
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Saccharomyces cerevisiae by an elegant screen based on a synthetic
protein complementing for mitochondria–ER tethering defects [99].
However, despite the fact that the “Ca2+microdomain” hypothesis was
taken for granted by most investigators thanks to the indirect
experimental evidence mentioned above, a direct proof of Ca2+
microdomains existence on mitochondrial surface was reached only
very recently by our group [100]. In order to monitor in the very same
cell OMMand bulk cytosolic Ca2+ variations upon cellular stimulation a
nuclear and a OMMnew generation FRET-based Ca2+ sensors ([60], see
section 2) were generated. In cells co-transfected with OMM and
nuclear targeted Ca2+ probes (challenged with an IP3 generating
stimulus) we found that the mean Ca2+ rise in the two compartments
appears almost indistinguishable (Fig. 1A). However, a more sophisti-
cated statistical analysis of the images reveals the existence of small
OMM, but not nuclear, regions whose [Ca2+] reaches values as high as
15–20 µM (Fig. 1B). An estimation made on the ﬁrst 4 s after the
stimulation shows that at least 10% of OMM surface is covered by these
hot spots during the transient increase in cytosolic Ca2+ elicited by IP3
production. Classical epiﬂuorescence and TIRF experiments were then
combined in order to monitor the generation of high Ca2+ micro-
domains in mitochondria located near plasma membrane. By this
approach we could show that Ca2+ hot spots on the surface of
mitochondria occur upon opening of voltage operated calcium channels
(VOCCs), but not upon capacitative Ca2+ entry (CCE). From these data
and also from those of Korzeniowski and colleagues [101], it can be
concluded that upon CCE activation the close apposition between Orai1
channels (located in the PM; [102]) and STIM1 (located in ER “punctae”
near PM; [103]) does not allow mitochondria to be in sufﬁcient
proximity to themouth of the PM channels to sense the local [Ca2+] hot
spots. The main mechanisms participating in mitochondrial Ca2+Fig. 1. A pixel by pixel correlation analysis uncovers Ca2+ microdomains on OMM upon
(N33D1cpv) targeted cameleons were treated with the IP3-coupled stimulus histamine (arro
and OMM (blue trace) are very similar. R is the ratio between YFP and CFP emission, R0 is
maximum ΔR/R0 value (ΔRmax/R0) reached by each single pixel of the nucleus (green) or OM
numerousness. The Gaussian ﬁt (red trace) of the distribution is superimposed to highlight t
details). (C) Yellow-to-red color representation ofΔRmax/R0 spatial distribution of pixels in 2
the 4 s after the histamine challenge have a ΔRmax/R0 exceeding 125% the ΔR/R0 of the whhomeostasis and Ca2+ microdomains generation are summarized in
Fig. 2.4. Mitochondrial Ca2+ handling and cell death
In the last decade, it has become clear that mitochondria, in
addition to their role as the cell powerhouse, have a key role in several
other processes of major importance in cell physiology and pathology
[25,26,104,105]. Notably, great attention has been paid to the role of
mitochondria in cell death. Indeed, although the extrinsic pathway for
apoptosis may or may not involve mitochondria, in the intrinsic
pathway these organelles perform a pivotal role: they release a
number of proapototic factors from the IMS that initiate the executor
caspase cascade (for review see [26,106]).
A main mechanism leading to the release of proapototic factors in
the cytosol is the formation of the “permeability transition pore,” also
known as mitochondrial megachannel (see also section 3.1). PTP has
been characterized functionally in a number of cell types. Remarkably,
its opening is favoured by excessive Ca2+ accumulation by mitochon-
dria (Ca2+ overload). The protein composition of PTP is still under
debate, although there is evidence that several OMM, IMS and IMM
proteins are involved in its regulation, namely: adenine nucleotide
translocase, hexokinase, peripheral-type benzodiazepine receptor,
voltage dependent anion channel, mitochondrial creatine kinase and
cyclophilin D (Cyp D) [26]. Surprisingly, in cells from knock out (KO)
mice of many of these proteins, PTP opening appears normal, with the
notable exception of cells from Cyp D KOmice. Genetic ablation of Cyp
D, in fact, leads to a delayed Cyclosporin A-insensitive PTP activation
in response to Ca2+ overload. PTP opening triggered by stimuli other
than Ca2+ overload, however, is similar in wild type and Cyp D KOcellular stimulation. HeLa cells co-transfected with nuclear-(H2BD1cpv) and OMM-
w in A). (A) The average [Ca2+] rise (here expressed as ΔR/R0) of nucleus (green trace)
the ratio at t=0 and ΔR the difference between R at any given time and R0. (B) The
M (blue) during the ﬁrst 4 s after histamine stimulation is expressed as a histogram of
he right tail due to hot-spot formation on OMM upon cellular stimulation (see [100] for
D (left) and 3D (right), superimposed to YFP ﬂuorescence image. Only pixels that during
ole compartment were color-coded. Scale bar, 5 µm.
Fig. 2.Mitochondrial Ca2+ toolbox. Arrows indicate ion ﬂuxes. Red arrows, Ca2+; blue arrows, H+; yellow arrow, Na+; green arrow, K+. ETC, electron transport chain. In the case of
Letm1, both hypotheses on its function are shown. The insets represent the main mechanisms causing a [Ca2+]m rise: the color of the square shaping each inset indicates if that
[Ca2+]m rise occurs without (green) or with (red) generation of Ca2+ microdomains on the OMM. See text for details.
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in this megachannel. [107–110].
Apoptosis is modulated by a number of proteins of the Bcl-2 family,
among which the classical proapototic proteins Bax and Bak and the
antiapoptotic Bcl-2 and Bcl-XL. These proteins reside in the ER, cytosol
andmitochondria as homoo heterodimers. Asmentioned above, during
apoptosis permeabilization of the OMMoccurswith release from IMS of
cytochrome c and other proapoptotic factors. Of interest, proapoptotic
proteins such as Bcl-2 affect ER–mitochondrial Ca2+ crosstalk, as the
over-expression of Bcl-2 reduces the Ca2+ content of the ER [111]
making the cells resistant to apoptosis. Similarly, genetic ablation of the
proapoptotic proteins Bax and Bak (that drastically increases the
resistance to death signals) also results in a dramatic reduction in ER
Ca2+ content (and consequently in a reduction of the Ca2+ that can be
transferred to mitochondria) [112]. Moreover, several different
approaches resulting in decreases of ER Ca2+ content protect cells
from apoptosis while, vice versa, an increase in Ca2+ within the ER
favours apoptosis triggered by a number of stimuli [113].
As to the mechanisms leading to OMM permeabilization a pivotal
role is playedbyBid andby thePTP [25,114].While Bid- (andother BH3-
only proapoptotic proteins) dependent OMM permeabilization is
insensitive to mitochondrial Ca2+, in many other situations the
apoptotic cascade (and OMM permeability) somehow relies on
mitochondrial Ca2+ overload. The concept of mitochondrial Ca2+
overload, however, does not necessarily refer solely to a very large
increase in [Ca2+]m. In fact very large, but short lasting, increases in
matrix Ca2+ may occur under several physiological conditions without
detrimental consequences for cell survival; rather, much smaller, but
prolonged, increases of Ca2+ may activate the apoptotic machinery.
Finally, most relevant for physiopathology, mitochondria can function
as coincidencedetectors for the apoptotic process, i.e. if a riseof Ca2+nottoxic in itself (and actually beneﬁcial because it increases the efﬁciency
of ATP synthesis) occurs synchronouslywith another toxic event, itmay
synergize with this insult and turn a beneﬁcial process into a death
stimulus [115,116].
Mitochondria are thus emerging as crucial players in the pathology
of many different diseases, both as primary or secondary executioners.
Indeed, apart from the primary cause, that is frequently far away from
mitochondria and even in the extracellular matrix (see below), many
diseases show as ﬁnal step a general Ca2+ deregulation that in turn
causesmitochondrial Ca2+overloadand cell death through PTPopening
and mitochondria swelling. For instance, Gandhi and co-workers found
impaired Ca2+ efﬂux from mitochondria through the Na+/Ca2+
exchanger in neurons lacking PINK1, a serine threonine kinase
implicated in autosomal recessive early-onset parkinsonism. This led
to increased Ca2+ uptake capacity, decreased membrane potential, and
increased ROS production, all leading to early triggering of the PTP
opening and concomitant neuronal death [117]. Blockade of this ﬁnal
process, no matter the original cause, is thus emerging as an effective
therapeutic strategy also in vivo. Indeed, genetic ablation or pharma-
cological inhibition of Cyp D, a main regulator of the PTP, has been
shown to decrease the mitochondrial alterations and ameliorate the
pathology both in the case of Collagen VI deﬁciency and in the Scgd−/−
mouse, a model for severe dystrophia [118,119]. In the following
section, we will review in more detail the relationship between altered
Ca2+ homeostasis and mitochondria in Alzheimer's disease.
4.1. Alzheimer's disease
AD is the most common human neurodegenerative disease,
currently affecting more than 20 million people worldwide. Although
AD cases are mostly sporadic, a small percentage (presumably less than
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Alzheimer's Disease (FAD) were identiﬁed in the early 1990s: current
statistics show that approximately 80% of FAD cases are due to
mutations in the presenilin-1 (PSEN-1) gene (with the most aggressive
phenotype and the earliest onset), 14% to mutations in the Amyloid-
Precursor Protein (APP) gene, and only 6% to mutations in the
presenilin-2 (PSEN-2) gene. Albeit accounting only for a minor
percentage of the total AD cases, FAD-mutations in these three genes
provided useful tools andmodels to investigate themechanisms behind
the pathology. Indeed, sporadic and familial AD have indistinguishable
histopathological phenotypes, including the two AD hallmarks, i.e.,
extracellular amyloid plaques, composed by aggregates of amyloid β
(Αβ) peptides derived from APP cleavage (see below), and intracellular
neuroﬁbrillary tangles, formedbyﬁlaments of hyperphosphorylated tau
protein [120–122].
APP is initially cleaved by two mutually exclusive enzymes, α- or
β-secretase, and subsequently by γ-secretase. Presenilin-1 and
presenilin-2 (PS1 and PS2) are the catalytic core of the γ-secretase
complex and the pathway that implies β- and γ-cleavage is called
“amyloidogenic”. Indeed the cleavage of APP by β and γ-secretase
leads to the generation of multiple Aβ peptides, mostly Aβ40 and
Aβ42, the latter being the most noxious and aggregation-prone
[123,124]. Although initially PS-FAD mutations were reported to
increase Aβ peptides generation, especially of the toxic Aβ42
species, in the last few years several data drastically changed this
view suggesting a total decreased γ-secretase activity in the
presence of PS-FAD mutants. Mutations would impair the cleavage
efﬁciency of PSs both reducing the total Aβ production and
promoting less precise cuts of APP stub with a major generation
of Aβ42 and thus a shift in Aβ42/Aβ40 ratio towards the more toxic
and amyloidogenic species (as reviewed in [125] and in [126]). It
should be also mentioned here that, although FAD is a central
nervous system pathology, APP and PSs are ubiquitously expressed.
Indeed, PSs play a key role in processes other than APP cleavage,
e.g., in the Notch signalling pathway, cell adhesion, intracellular
trafﬁcking regulation, GSK3β modulation, and Ca2+ signalling (see
[127,128]).
It is noteworthy that alterations in Ca2+ homeostasis in sporadic
AD patients started being reported in themiddle of the 1980s, albeit in
contrasting ways [129–131]. Moreover, the link between AD and Ca2+
dysregulation became more evident with studies on FAD mutations,
especially in PSs, that have revealed strong–and controversial–effects
on Ca2+ signalling (for recent reviews see [132–134].
The ﬁrst hypothesis on FAD-linked Ca2+ dysregulation is the
so-called Ca2+ overload hypothesis, stating that FAD-PSs should lead
to an increased Ca2+ content in cellular stores and consequently to an
exaggerated Ca2+ release upon stimulation [135–138]. Amajor support
to the Ca2+ overload hypothesis came from the demonstration that PSs
can form low conductance Ca2+-leak channels in the ER membrane
essential in the maintenance of a physiological [Ca2+] inside ER; the
permeability of the channels to ionswas reported to be impaired by FAD
mutations, thus leading to an increase in [Ca2+]ER and to a bigger
cytosolic Ca2+ increase upon stimulation [139,140].
An alternative model is that proposed recently by Cheung and co-
workers [141]. These authors have shown that PSs (and especially FAD-
linked PSsmutants) positivelymodulate IP3Rs, sensitizing the receptors
to low concentration of IP3. According to this model, the ﬁnal effect of
mutated PSs is to augment Ca2+ release from the ER at low,
physiological, agonist concentrations [141]. Notably, Cheung et al.
reported that FAD-PSs cause a slight, but measurable decrease in
[Ca2+]ER [141]. Increase opening probability of IP3R (at low IP3
concentrations) has been very recently demonstrated also in B
lymphoblast from FAD patients by nuclear patch clamp electrophysi-
ology [142]. Hypersensitivity of the IP3 signalling pathway in cells from
FAD models was also suggested by previous works in intact neurons
[143], and evidence for abnormal hyperactivity and/or increasedexpression of the other ER Ca2+-releasing channel, the RyR, has been
also reported [144–147]. In addition, Carafoli's group reported an
interaction between PS2 and the Ca2+-binding protein DREAM, leading
to reduced ER Ca2+ levels by acting on IP3R expression [148].
A third group of laboratories, including our own, have found that PSs
(and more effectively FAD-PS2 expression) substantially reduce
[Ca2+]ER. For example, we showed that in human ﬁbroblasts from FAD
patients, as well as in primary mouse cortical neurons over-expressing
FAD-PS1/2, there is a clear reduction of Ca2+ release from intracellular
stores when compared to controls. Moreover, by employing ER- and
Golgi-targeted aequorins to directly evaluate the [Ca2+] within these
compartments, it was clearly shown that in PS2- and, to a lower extent,
in PS1-transfected cells there is a reduction in [Ca2+] within the stores
[149–151]. Consistent with these ﬁndings, recent data demonstrated a
Ca2+ deﬁcit in neurons from D. melanogaster expressing FAD-PS1/2
compared to control neurons, an effect that seems to require CaM [152].
Last, but not least, while Tu and colleagues [139] reported thatMEF cells
knockdown for PS1 and2havean increased [Ca2+]ER, Kasri et al al. [153]
reported, using the same cells, a reduced Ca2+ contentwithin the stores,
and data from our lab showed no signiﬁcant difference between wild
type and PS1/PS2 KO cells in terms of [Ca2+]ER [154]. The reduced level
of [Ca2+] in the stores of FAD-PSs over-expressing cells has been
attributed to an increased Ca2+ leak through IP3Rs and/or RyRs (thus in
agreement with the results of [141]) and to a reduction in the SERCA
activity (see below) [154].
Indeed, the SERCA has been proposed to be a major target of PSs: La
Ferla and colleagues [155], based on a series of indirect data, suggested
that the SERCA is regulated by PSs (in particular PS2) and hyper-
activated by FAD-PS1. Opposite results were obtained however
considering PS2 FAD mutants and directly measuring ER Ca2+ uptake
with ER-targeted aequorin [154]: (FAD)-PS2 over-expression results in
a strong inhibition of SERCA activity and appears to be a major
component of the PS2 dependent reduction of [Ca2+]ER.
Given the contradictory experimental ﬁndings reported above, it is
difﬁcult to draw a ﬁrm and unbiased conclusion about the role of PSs
on ER Ca2+ homeostasis. On the one hand, the groups of Bezproz-
vanny and La Ferla have provided strong evidence, though often
indirect, supporting the hypothesis that FAD linked mutations lead to
ER Ca2+ overload, due to a reduced leak and/or stimulation of the
SERCA. On the other hand, our group and that of Foskett, by direct
investigation of the activity of the channels, of the Ca2+ pumps, and of
the [Ca2+] within the lumen of organelles, have generated data
showing that mutated PSs tend to reduce the Ca2+ level in the ER,
either by increasing the sensitivity to IP3 or by inhibiting the activity
of the SERCA, or a mixture of both. The reason for these experimental
discrepancies remains at present unknown and is particularly
intriguing since, in many cases, the exact same cell types were used
by the different groups. Most relevant (and again unlike the results
obtained by the groups of Bezprozvanny and La Ferla), our data
indicate that, in terms of Ca2+ handling by the ER, there is a major
difference between PS2 and PS1 (wild type and FAD linked), with PS1
having a minor, almost negligible effect on ER Ca2+ levels. These
striking and unexpected differences between PS1 and PS2 on ER Ca2+
handling have recently been independently conﬁrmed by Carafoli's
group (E. Carafoli's personal communication).
The scenario becomes even more complex when considering
the effects of Aβ peptides. These have been proposed to affect
cellular Ca2+ homeostasis in many different (and also controver-
sial) ways. A detailed discussion of this topic is beyond the scope
of this review but the reader is referred to recent literature on
the matter [132,133,156]). We should mention, however, some
recent reports that address speciﬁc aspects of this issue: altered
Ca2+ regulation was found in spines and dendrites in neurons
proximal to Aβ deposits [157]; Aβ oligomers were reported to
cause Ca2+ entry in neurons (and consequent mitochondrial Ca2+
overload) [158], as well as toxic activation of ionotropic glutamate
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also been described [160]. Moreover, massive Ca2+ transfer
between ER and mitochondria has been reported upon exposure
of cultured cortical neurons to Aβ (and prion protein) [161].
An open problem in the ﬁeld of AD and Ca2+ dys-homeostasis that
has been only superﬁcially investigated thus far is mitochondrial Ca2+
handling. As discussed above, any defect in cytosolic Ca2+ release/
clearance inevitably impinges on mitochondria and affects their
activity [5]. The above-mentioned AD-linked alteration in Ca2+
signalling should be considered also from the mitochondrial perspec-
tive, especially because mitochondrial deﬁcits have already been
reported in most neurodegenerative diseases [162] and more
speciﬁcally in AD [163,164]. Alteration in mitochondrial morphology
and/or distribution has been found in neurons from brains of AD
patients [165,166] and as a consequence of Tau (both in its wild type
and mutated forms, [167,168]; APP [169] and FAD-Presenilin-1 [170]
expression in different experimental models, and also in an Aβ42-
over-expressing D. melanogaster [171]. In addition, FAD PS1 has been
reported to exacerbate the mitochondrial toxicity of several stimuli
[172,173] and mitochondrial deﬁcits appear to be early events in the
development of AD [174]. Of particular interest on this topic is the
recent report that PSs are enriched in ER Mitochondria-Attached
Membranes (MAMs) [175]; i.e. domains of the ER that closely and
preferentially interact with mitochondria and are endowed with key
players for Ca2+ handling [176–178].
Wehave recently focussed our attentionon this aspect andwehave
found that PS2 over-expression increases the interaction between ER
and mitochondria, an effect that is greater for FAD variants; as a
consequence, a favoured Ca2+ transfer between ER and mitochondria
can be measured upon over-expression of (FAD)-PS2 in cell lines. The
pathophysiological consequences of this new and unexpected action
of PS2 are still under investigation, but it is possible to speculate that
this favoured interaction could potentially result in a toxic mitochon-
drial Ca2+ overload (see [95]) or, alternatively, in a compensatory
phenomenon ensuring proper Ca2+ signalling to mitochondria in the
presence of a reduced [Ca2+]ER (see [154]); on the other hand, an
enhanced recruitment of mitochondria close to ER could be also a
consequence of a dysfunction in Ca2+ handling by the store, since
mitochondria dynamics are known to be tightly regulated by Ca2+ (as
reviewed in [179]).
5. Conclusions
Fifty years of research on mitochondria and their role in Ca2+
homeostasis have clariﬁed the main players of this process and the
principal functions for which they are responsible, ranging, as
discussed in this review, from the regulation of cell's energy supply
to the control of the intrinsic pathway of apoptosis. However,
mitochondria and their Ca2+ handling machinery are still extremely
intriguing and continue to tease investigators towards a deeper
comprehension of their multifaceted nature. The tremendous
improvements achieved in the measurement of intracellular Ca2+,
mainly due to the optimization of GECIs, have signiﬁcantly contributed
to the advancements in these studies. The use of these GECIs in vivo,
although still complex and technically demanding, seems to be
particularly promising for the future of this ﬁeld, opening completely
new insights in the investigation of Ca2+ dynamics in physiology and
also in the numerous diseases where cellular (and in particular
mitochondrial) Ca2+ homeostasis is deregulated, both as primary
cause or as a secondary effect of the pathology.
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